₹1,850.70-38.90 (-2.06%)
04:01 PM, 5-Feb-2026₹1,849.20-40.50 (-2.14%)
03:46 PM, 5-Feb-2026BSE : 543245
NSE : GLAND
Sector : Health care
ISIN Code : INE068V01023
Last Updated: 05-Feb-2026 | 04:01 PM IST
| Market Cap (₹ Cr) | 30,500 |
Traded Value (₹ Cr) | 0.32 |
Volume (Shares) | 1,729 |
Face Value (₹) | 1 |
52-Week High (₹) | 2,130.00 |
52-Week High Date | 29-Jul-2025 |
52-Week Low (₹) | 1,200.00 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 4,350.00 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 861.50 |
All Time Low Date | 22-May-2023 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 30,475 |
| EPS - TTM (₹) [C] | 51.42 |
| P/E Ratio (X) [C] | 35.96 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 1,800.00 |
| Latest Dividend Date | 14-Aug-2025 |
| Dividend Yield (%) | 0.95 |
| Book Value Share (₹) [C] | 580.41 |
| P/B Ratio (₹) [C] | 3.19 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| UTI-Flexi Cap Fund (IDCW) | 145.56 | 7,88,274 | 0.62 |
| UTI-Flexi Cap Fund (G) | 145.56 | 7,88,274 | 0.62 |
| UTI-Flexi Cap Fund - Direct (G) | 145.56 | 7,88,274 | 0.62 |
| UTI-Flexi Cap Fund - Direct (IDCW) | 145.56 | 7,88,274 | 0.62 |
| UTI-Mid Cap Fund (IDCW) | 95.10 | 5,15,000 | 0.83 |
| UTI-Mid Cap Fund (G) | 95.10 | 5,15,000 | 0.83 |
| UTI-Mid Cap Fund - Direct (G) | 95.10 | 5,15,000 | 0.83 |
| UTI-Mid Cap Fund - Direct (IDCW) | 95.10 | 5,15,000 | 0.83 |
| UTI-MNC Fund (IDCW) | 78.44 | 4,24,791 | 2.85 |
| UTI-MNC Fund (G) | 78.44 | 4,24,791 | 2.85 |
Load more
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| 25-Sep-2025 | Motilal Oswal | Buy | 2,340 | |
| 04-Feb-2025 | Elara Capital | Buy | 1,841 | |
| 06-Nov-2024 | Motilal Oswal | Buy | 1,970 |
| Today's Low/High (₹) | 1,845.20 1,899.90 |
| Week Low/High (₹) | 1,745.70 1,985.00 |
| Month Low/High (₹) | 1,650.00 1,985.00 |
| Year Low/High (₹) | 1,277.80 2,131.00 |
| All time Low/High (₹) | 861.50 4,350.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 2.77% | 2.73% | 0.91% | 0.88% |
| 1 Month | 8.89% | 8.89% | -2.49% | -2.31% |
| 3 Month | -3.32% | -3.27% | -0.17% | 0.18% |
| 6 Month | -5.87% | -5.88% | 3.23% | 4.03% |
| 1 Year | 23.52% | 23.51% | 6.44% | 8.21% |
| 3 Year | 52.41% | 52.66% | 36.94% | 43.62% |
Chairman / Executive Director / MD / CEO : SRINIVAS SADU
Independent Non Exe. Director : UDO JAHANNES VETTER
Independent Non Exe. Director : Satyanarayana Murthy Chavali
Independent Non Exe. Director : ESSAJI GOOLAM VAHANVATI
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Independent Non Exe. Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Wenjie Zhang
Non-Exec & Non-Independent Dir : Wei Huang
CS / Compliance Officer / Vice President : SAMPATH KUMAR PALLERLAMUDI
Registered Office: Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal,Hyderabad,Telangana-500043 Ph: 91-40-30510999
1. What's the Gland Pharma Ltd share price today?
Gland Pharma Ltd share price was Rs 1,850.70 at 04:01 PM IST on 5th Feb 2026. Gland Pharma Ltd share price was down by 2.06% from the previous closing price of Rs 1,889.60. Gland Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Gland Pharma Ltd stock?
The performance of the Gland Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Gland Pharma Ltd?
Gland Pharma Ltd has a market capitalisation of Rs 30,500 crore.
4. What is Gland Pharma Ltd's 52-week high/low share price?
The Gland Pharma Ltd’s 52-week high share price is Rs 2,130.00 and 52-week low share price is Rs 1,200.00.
5. Is the Gland Pharma Ltd profitable?
On a consolidated basis, Gland Pharma Ltd reported a profit of Rs 261.48 crore on a total income of Rs 1,758.54 crore for the quarter ended 2025.
6. Which are Gland Pharma Ltd’s peers in the Health care sector?
Gland Pharma Ltd’s top 5 peers in the Health care sector are Ipca Labs., Anthem Bioscienc, Ajanta Pharma, Gland Pharma, J B Chemicals &, Emcure Pharma, Wockhardt.
7. Who owns how much in Gland Pharma Ltd?
Key changes to the Gland Pharma Ltd shareholding are as follows: